Display options
Share it on

Acta Histochem Cytochem. 2006 Jul 01;39(3):95-100. doi: 10.1267/ahc.06005. Epub 2006 May 26.

Survivin as a prognostic factor for osteosarcoma patients.

Acta histochemica et cytochemica

Eiji Osaka, Takashi Suzuki, Shunzo Osaka, Yukihiro Yoshida, Hideyuki Sugita, Satoru Asami, Keiichi Tabata, Akihiro Hemmi, Masahiko Sugitani, Norimichi Nemoto, Junnosuke Ryu

Affiliations

  1. Department of Orthopaedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchikamimachi, Itabashi-ku, Tokyo 173-8610, Japan. [email protected]

PMID: 17327929 PMCID: PMC1790971 DOI: 10.1267/ahc.06005

Abstract

PURPOSE: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult -tissues. However, survivin expression has been detected in various human cancers and -correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we investigated the correlations between survivin mRNA expression in osteosarcoma tissues and clinicopathological parameters.

METHODS: There were 22 osteosarcoma patients in our hospital with paraffin-embedded -tissues which could be extracted from biopsy specimens. We used the RT-PCR method after extracting total RNA and conducted a densitometric analysis to determine the ratio of survivin relative to h-GAPDH as an internal marker.

RESULTS: Expression of survivin mRNA was detected in all osteosarcoma samples. Patients with metastasis had high survivin mRNA levels in initial biopsy specimens (p<0.01). Moreover, there was a statistically significant difference in survivin mRNA expression between -patients with and without metastasis (p<0.01).

CONCLUSION: We concluded that high levels of survivin mRNA expression suggest poor prognosis for osteosarcoma patients.

References

  1. Biotechniques. 1991 Sep;11(3):304, 306, 308 - PubMed
  2. Oncogene. 2000 Feb 3;19(5):617-23 - PubMed
  3. Diagn Mol Pathol. 1997 Apr;6(2):91-7 - PubMed
  4. Eur J Surg Oncol. 2003 May;29(4):379-82 - PubMed
  5. Clin Chem. 2004 Nov;50(11):1986-93 - PubMed
  6. J Clin Oncol. 2002 Feb 1;20(3):776-90 - PubMed
  7. Gut. 2000 May;46(5):645-50 - PubMed
  8. Surgery. 2004 Aug;136(2):443-8 - PubMed
  9. Diagn Mol Pathol. 1998 Apr;7(2):96-101 - PubMed
  10. Prog Clin Biol Res. 1985;201:39-51 - PubMed
  11. J Korean Med Sci. 1998 Aug;13(4):395-9 - PubMed
  12. Int J Cancer. 2001 Nov 20;95(6):360-3 - PubMed
  13. Cancer Res. 1998 Dec 1;58(23):5315-20 - PubMed
  14. Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20 - PubMed
  15. Med Sci Monit. 2003 Apr;9(4):PI25-9 - PubMed
  16. Rinsho Byori. 2001 Mar;49(3):278-82 - PubMed
  17. Biotechniques. 1993 Mar;14(3):448-53 - PubMed
  18. Gastric Cancer. 2003;6(4):217-24 - PubMed
  19. World J Gastroenterol. 2004 Nov 15;10(22):3245-50 - PubMed
  20. J Clin Oncol. 1999 Jul;17(7):2100-4 - PubMed
  21. Am J Pathol. 1998 Dec;153(6):1807-12 - PubMed
  22. Diagn Mol Pathol. 1996 Jun;5(2):107-13 - PubMed
  23. J Cancer Res Clin Oncol. 2004 Aug;130(8):487-90 - PubMed
  24. Mod Pathol. 1996 Jun;9(6):703-9 - PubMed
  25. Nat Med. 1997 Aug;3(8):917-21 - PubMed
  26. J Mol Diagn. 2003 Feb;5(1):34-41 - PubMed
  27. Biochem J. 1997 Aug 15;326 ( Pt 1):1-16 - PubMed

Publication Types